250 related articles for article (PubMed ID: 27348472)
1. Evidence for an important role of both complement-binding and noncomplement-binding donor-specific antibodies in renal transplantation.
Viglietti D; Lefaucheur C; Glotz D
Curr Opin Organ Transplant; 2016 Aug; 21(4):433-40. PubMed ID: 27348472
[TBL] [Abstract][Full Text] [Related]
2. From Humoral Theory to Performant Risk Stratification in Kidney Transplantation.
Lefaucheur C; Viglietti D; Mangiola M; Loupy A; Zeevi A
J Immunol Res; 2017; 2017():5201098. PubMed ID: 28133619
[TBL] [Abstract][Full Text] [Related]
3. Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis.
Gosset C; Viglietti D; Rabant M; Vérine J; Aubert O; Glotz D; Legendre C; Taupin JL; Duong Van-Huyen JP; Loupy A; Lefaucheur C
Kidney Int; 2017 Sep; 92(3):729-742. PubMed ID: 28554738
[TBL] [Abstract][Full Text] [Related]
4. Complement-binding anti-HLA antibodies and kidney-allograft survival.
Loupy A; Lefaucheur C; Vernerey D; Prugger C; Duong van Huyen JP; Mooney N; Suberbielle C; Frémeaux-Bacchi V; Méjean A; Desgrandchamps F; Anglicheau D; Nochy D; Charron D; Empana JP; Delahousse M; Legendre C; Glotz D; Hill GS; Zeevi A; Jouven X
N Engl J Med; 2013 Sep; 369(13):1215-26. PubMed ID: 24066742
[TBL] [Abstract][Full Text] [Related]
5. DSA in solid organ transplantation: is it a matter of specificity, amount, or functional characteristics?
Louis K; Lefaucheur C
Curr Opin Organ Transplant; 2022 Oct; 27(5):392-398. PubMed ID: 35881421
[TBL] [Abstract][Full Text] [Related]
6. Determining donor-specific antibody C1q-binding ability improves the prediction of antibody-mediated rejection in human leucocyte antigen-incompatible kidney transplantation.
Malheiro J; Tafulo S; Dias L; Martins S; Fonseca I; Beirão I; Castro-Henriques A; Cabrita A
Transpl Int; 2017 Apr; 30(4):347-359. PubMed ID: 27717025
[TBL] [Abstract][Full Text] [Related]
7. Complement-Activating Anti-HLA Antibodies in Kidney Transplantation: Allograft Gene Expression Profiling and Response to Treatment.
Lefaucheur C; Viglietti D; Hidalgo LG; Ratner LE; Bagnasco SM; Batal I; Aubert O; Orandi BJ; Oppenheimer F; Bestard O; Rigotti P; Reisaeter AV; Kamar N; Lebranchu Y; Duong Van Huyen JP; Bruneval P; Glotz D; Legendre C; Empana JP; Jouven X; Segev DL; Montgomery RA; Zeevi A; Halloran PF; Loupy A
J Am Soc Nephrol; 2018 Feb; 29(2):620-635. PubMed ID: 29042454
[TBL] [Abstract][Full Text] [Related]
8. Complement-fixing donor-specific anti-HLA antibodies and kidney allograft failure.
Cazarote HB; Shimakura S; Valdameri JS; Contieri FLC; von Glehn CQC; Aita CM; Susin MF; Sotomaior VS; Glehn-Ponsirenas R
Transpl Immunol; 2018 Aug; 49():33-38. PubMed ID: 29596992
[TBL] [Abstract][Full Text] [Related]
9. Anti-human leukocyte antigen immunization after early allograft nephrectomy.
Del Bello A; Congy N; Sallusto F; Cardeau-Desangles I; Fort M; Esposito L; Guitard J; Cointault O; Lavayssière L; Nogier MB; Game X; Blancher A; Rostaing L; Kamar N
Transplantation; 2012 May; 93(9):936-41. PubMed ID: 22361471
[TBL] [Abstract][Full Text] [Related]
10. Donor-specific antibody characteristics, including persistence and complement-binding capacity, increase risk for chronic lung allograft dysfunction.
Iasella CJ; Ensor CR; Marrari M; Mangiola M; Xu Q; Nolley E; Moore CA; Morrell MR; Pilewski JM; Sanchez PG; McDyer JF; Zeevi A
J Heart Lung Transplant; 2020 Dec; 39(12):1417-1425. PubMed ID: 32981841
[TBL] [Abstract][Full Text] [Related]
11. Donor-Specific HLA Antibodies: A Review of Data Published in 2016.
Idica A; Everly MJ
Clin Transpl; 2016; 32():13-22. PubMed ID: 28564519
[TBL] [Abstract][Full Text] [Related]
12. The role of immunoglobulin-G subclasses and C1q in de novo HLA-DQ donor-specific antibody kidney transplantation outcomes.
Freitas MC; Rebellato LM; Ozawa M; Nguyen A; Sasaki N; Everly M; Briley KP; Haisch CE; Bolin P; Parker K; Kendrick WT; Kendrick SA; Harland RC; Terasaki PI
Transplantation; 2013 May; 95(9):1113-9. PubMed ID: 23514959
[TBL] [Abstract][Full Text] [Related]
13. Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis.
Bouquegneau A; Loheac C; Aubert O; Bouatou Y; Viglietti D; Empana JP; Ulloa C; Murad MH; Legendre C; Glotz D; Jackson AM; Zeevi A; Schaub S; Taupin JL; Reed EF; Friedewald JJ; Tyan DB; Süsal C; Shapiro R; Woodle ES; Hidalgo LG; O'Leary J; Montgomery RA; Kobashigawa J; Jouven X; Jabre P; Lefaucheur C; Loupy A
PLoS Med; 2018 May; 15(5):e1002572. PubMed ID: 29799874
[TBL] [Abstract][Full Text] [Related]
14. Donor-specific HLA antibodies: evaluating the risk for graft loss in renal transplant recipients with isotype switch from complement fixing IgG1/IgG3 to noncomplement fixing IgG2/IgG4 anti-HLA alloantibodies.
Arnold ML; Ntokou IS; Doxiadis II; Spriewald BM; Boletis JN; Iniotaki AG
Transpl Int; 2014 Mar; 27(3):253-61. PubMed ID: 24118579
[TBL] [Abstract][Full Text] [Related]
15. Effect of C1q-binding donor-specific anti-HLA antibodies on the clinical outcomes of patients after renal transplantation: A systematic review and meta-analysis.
Kang ZY; Liu C; Liu W; Li DH
Transpl Immunol; 2022 Jun; 72():101566. PubMed ID: 35257893
[TBL] [Abstract][Full Text] [Related]
16. Complement-binding anti-HLA antibodies are independent predictors of response to treatment in kidney recipients with antibody-mediated rejection.
Viglietti D; Bouatou Y; Kheav VD; Aubert O; Suberbielle-Boissel C; Glotz D; Legendre C; Taupin JL; Zeevi A; Loupy A; Lefaucheur C
Kidney Int; 2018 Oct; 94(4):773-787. PubMed ID: 29801667
[TBL] [Abstract][Full Text] [Related]
17. IgG Donor-Specific Anti-Human HLA Antibody Subclasses and Kidney Allograft Antibody-Mediated Injury.
Lefaucheur C; Viglietti D; Bentlejewski C; Duong van Huyen JP; Vernerey D; Aubert O; Verine J; Jouven X; Legendre C; Glotz D; Loupy A; Zeevi A
J Am Soc Nephrol; 2016 Jan; 27(1):293-304. PubMed ID: 26293822
[TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A
Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
[TBL] [Abstract][Full Text] [Related]
19. C3d-binding Donor-specific HLA Antibody Is Associated With a High Risk of Antibody-mediated Rejection and Graft Loss in Stable Kidney Transplant Recipients: A Single-center Cohort Study.
Lee DR; Kim BC; Kim JP; Kim IG; Jeon MY
Transplant Proc; 2018 Dec; 50(10):3452-3459. PubMed ID: 30503524
[TBL] [Abstract][Full Text] [Related]
20. Impact of donor-specific antibodies on results of liver transplantation.
O'Leary JG; Klintmalm GB
Curr Opin Organ Transplant; 2013 Jun; 18(3):279-84. PubMed ID: 23591739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]